Thu, May 26, 2022 11:00 AM – 12:00 PM EDT Register>> As the call for more diversity in clinical research grows, new approaches are needed to ensure patients of different genders, ethnicities, income brackets, and other under-represented populations are included in the evaluation of treatment access, effectiveness, and safety. Real-world data (RWD) can help with[…]
Thu, Apr 21, 2022 11:00 AM – 12:00 PM EDT Register>> There has been substantial recent progress in new heart failure (HF) treatments, yet there is still a large unmet need in the treatment of HF with preserved, mid-range, and reduced ejection fraction as well those with co-morbidities. Linked real-world data (RWD) can provide a[…]
BioPharma Dive Online April 4, 2022 Read the Full Article >> The large quantity of digitized healthcare data in the U.S., combined with advancements in data collection and processing technologies, present an enormous opportunity to shift dramatically how post-marketing safety studies can and should be conducted. The Traditional Approach Post-marketing safety studies are a[…]
Read the Press Release>> BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric[…]
Pharmaceutical Executive Online Published: March 15, 2022 Read the Full Article >> If you were asked which health care conditions rank as the highest in both unmet need and in cost, which would you choose? Would it be cancer or heart disease? While those conditions certainly place in both categories, mental health outranks them in[…]
